Grant Avenue Capital has launched a new integrated clinical site organisation, Helios Clinical Research, which will offer equitable access to quality research.

Helios optimises clinical research by partnering with patients, physicians, and biopharma sponsors.

Operating 20 integrated clinical research sites across four states, the company expects to strategically expand its US footprint over time. 

These sites specialise in metabolic, urology, vaccines, orthopaedics, dermatology, gastroenterology, oncology, and broader general medicine.

Helios’ team includes CEO E.B. McLindon, MD, chairman Stephen DeCherney, chief financial officer and chief operating officer Natalie Gassen, and senior vice-president and Business Development Head Sergio Armani.

Grant Avenue partner Preston Brice said: “We are launching Helios at a time when the need for a centralised solution to accelerate clinical research has never been greater. 

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“By building Helios with best-in-class companies and bringing together individuals we view as the most talented and accomplished in the industry, we believe we are well positioned to deliver a highly optimised solution to patients, physicians, and sponsors.”

The research sites of Helios engage, educate, and provide patients with a quality setting for taking part in clinical research as a care option.

They also support physicians by simplifying the process related to clinical research to help them focus on optimal patient care and collection of data.

Dr DeCherney said: “We have already formed an expert clinical development team that engages patients and sites across the US to modernise the research experience and help sponsors recruit and retain patients.

“Looking ahead, we believe the stable foundation of Helios, coupled with the financial and operational support that Grant Avenue provides, will meaningfully differentiate Helios from its competitors and enable us to continue to scale for success long into the future.”

For the formation of Helios, Lincoln International served as the financial advisor to Grant Avenue.